Compare HYPR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYPR | CPIX |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.3M | 98.3M |
| IPO Year | 2021 | 2007 |
| Metric | HYPR | CPIX |
|---|---|---|
| Price | $0.79 | $6.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $1.59 | N/A |
| AVG Volume (30 Days) | ★ 489.6K | 66.6K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.21 | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | $13,563,000.00 | ★ $42,010,949.00 |
| Revenue This Year | $50.75 | N/A |
| Revenue Next Year | $29.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.22 | ★ 16.75 |
| 52 Week Low | $0.79 | $1.85 |
| 52 Week High | $2.22 | $9.28 |
| Indicator | HYPR | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 29.06 | 39.53 |
| Support Level | N/A | $5.55 |
| Resistance Level | $1.39 | $8.27 |
| Average True Range (ATR) | 0.04 | 0.62 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 5.22 | 6.25 |
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.